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Résumé en
anglais
Ketogenic diet (KD) which combined carbohydrate restriction and the addition of
ketone bodies has emerged as an alternative metabolic intervention used as an
anticonvulsant therapy or to treat different types of neurological or mitochondrial
disorders including MELAS syndrome. MELAS syndrome is a severe mitochondrial
disease mainly due to the m.3243A > G mitochondrial DNA mutation. The broad
success of KD is due to multiple beneficial mechanisms with distinct effects of very low
carbohydrates and ketones. To evaluate the metabolic part of carbohydrate restriction,
transmitochondrial neuronal-like cybrid cells carrying the m.3243A > G mutation,
shown to be associated with a severe complex I deficiency was exposed during 3 weeks
to glucose restriction. Mitochondrial enzyme defects were combined with an
accumulation of complex I (CI) matrix intermediates in the untreated mutant cells,
leading to a drastic reduction in CI driven respiration. The severe reduction of CI was
also paralleled in post-mortem brain tissue of a MELAS patient carrying high mutant
load. Importantly, lowering significantly glucose concentration in cell culture improved
CI assembly with a significant reduction of matrix assembly intermediates and
respiration capacities were restored in a sequential manner. In addition, OXPHOS
protein expression and mitochondrial DNA copy number were significantly increased
in mutant cells exposed to glucose restriction. The accumulation of CI matrix
intermediates appeared as a hallmark of MELAS pathophysiology highlighting a
critical pathophysiological mechanism involving CI disassembly, which can be
alleviated by lowering glucose fuelling and the induction of mitochondrial biogenesis,
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